| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/20/2001 | EP1107995A2 Bifunctional antibodies and their use in targeting anti-tumour agents |
| 06/20/2001 | EP1107990A1 High-affinity antibodies |
| 06/20/2001 | EP1107989A2 Expression and export of angiostatin and endostatin as immunofusins |
| 06/20/2001 | EP1107978A1 Secreted proteins and polynucleotides encoding them |
| 06/20/2001 | EP1107977A1 Ratc |
| 06/20/2001 | EP1107971A1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them |
| 06/20/2001 | EP1107969A2 Collections of compounds |
| 06/20/2001 | EP1107964A1 Isoquinoline derivatives with angiogenesis inhibiting activity |
| 06/20/2001 | EP1107963A1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 06/20/2001 | EP1107962A1 Quinolin-2-one derivatives useful as anticancer agents |
| 06/20/2001 | EP1107958A1 Pyrimidine compounds |
| 06/20/2001 | EP1107957A1 Pyrimidine compounds |
| 06/20/2001 | EP1107953A1 Hydroxamic acid derivatives as proteinase inhibitors |
| 06/20/2001 | EP1107940A1 Vitamin d3 mimics |
| 06/20/2001 | EP1107798A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 06/20/2001 | EP1107797A2 Hypoxia regulated genes |
| 06/20/2001 | EP1107795A2 Methods and compositions for the prevention or treatment of cancer |
| 06/20/2001 | EP1107789A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/20/2001 | EP1107788A1 Scrp-5: secreted cysteine rich protein-5 |
| 06/20/2001 | EP1107784A2 Activation and protection of t-cells (cd4?+ and cd8?+ ) using an h 2? receptor agonist and other t-cell activating agents |
| 06/20/2001 | EP1107780A2 Selective treatment of endothelial somatostatin receptors |
| 06/20/2001 | EP1107774A1 Ramp2a: receptor activity modifying protein-2a |
| 06/20/2001 | EP1107751A2 Medicament containing platinum complex compounds and the use thereof |
| 06/20/2001 | EP1107750A2 Pharmaceutical composition with antitumor activity on the basis of carboplatin |
| 06/20/2001 | EP1107741A1 Orally administered controlled drug delivery system providing temporal and spatial control |
| 06/20/2001 | EP1107738A1 Novel pharmaceutical salt form |
| 06/20/2001 | EP1107707A1 Stent coating |
| 06/20/2001 | EP0889875B1 Cyclopropyl alkanoic acid derivatives |
| 06/20/2001 | EP0796260B1 Rapamycin 42-oximes and hydroxylamines |
| 06/20/2001 | EP0768308B1 derivatives of pyroglutaminic acid, preparation process and applications |
| 06/20/2001 | EP0694304B1 An extract of freshwater mussel, methods of the extraction and uses thereof |
| 06/20/2001 | EP0618962B1 Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis |
| 06/20/2001 | CN1300291A Modulators of protein tyrosine phosphatases |
| 06/20/2001 | CN1300289A Novel cephalotaxane derivatives and process for their preparation |
| 06/20/2001 | CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 06/20/2001 | CN1300218A Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 06/20/2001 | CN1299834A Ginkgo Testa Polysaccharide and the preparation of pharmaceutical thereof |
| 06/20/2001 | CN1299833A Human vessel endothelium growth factor resisting single stranded antibody and its preparation |
| 06/20/2001 | CN1299826A Colored mistletoe herb glycoprotein extraction and its medicine composite and preparation |
| 06/20/2001 | CN1299678A Chinese medicine shennongjingguling |
| 06/20/2001 | CN1299677A Cancer treating Tibetans medicine and its preparation |
| 06/20/2001 | CN1299674A Preparation of cancer treating medicine |
| 06/20/2001 | CN1299673A Preparation of cancer treating medicine capsule |
| 06/20/2001 | CN1299664A Common peganum herb oral liquid |
| 06/20/2001 | CN1299658A Medicine powder for eliminating tumor and cancer |
| 06/20/2001 | CN1067460C Pumping device |
| 06/20/2001 | CN1067392C Stable crystalline tetrahydrofolic acid salts |
| 06/20/2001 | CN1067384C Adhesion receptor antagonists, its preparation method and use as farm chemicals |
| 06/20/2001 | CN1067275C Snow ganoderma lucidum oral liquid |
| 06/20/2001 | CN1067274C Snow ganoderma lucidum solid medicament |
| 06/20/2001 | CN1067263C Xiaoaisan powder for curing cancer |
| 06/19/2001 | US6248865 Compounds useful for the synthesis of dolastatin analogs |
| 06/19/2001 | US6248864 Compounds and methods and modulating tissue permeability |
| 06/19/2001 | US6248787 Reducing cachexia |
| 06/19/2001 | US6248783 Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents |
| 06/19/2001 | US6248780 Therapy for breast cancer |
| 06/19/2001 | US6248771 Formulations for hydrophobic pharmaceutical agents |
| 06/19/2001 | US6248753 Bicyclic compounds |
| 06/19/2001 | US6248742 Administering dna protective agent/anticarcinogenic agent for treatment of oxidative stress manifested in infections and inflammations |
| 06/19/2001 | US6248738 Isoquinolines as urokinase inhibitors |
| 06/19/2001 | US6248712 Urokinase-type plasminogen activator receptor |
| 06/19/2001 | US6248594 Kinesin-like motor protein |
| 06/19/2001 | US6248576 Histidinol dehydrogenase |
| 06/19/2001 | US6248368 Administering magnesium salt |
| 06/19/2001 | US6248367 Bovine excretion extracts having anticancer and anti-inflammatory activity and process for preparing the same |
| 06/19/2001 | US6248363 Improved delivery of hydrophilic or hydrophobic pharmaceutical active ingredients, such as drugs, nutraceuticals, cosmeceuticals and diagnostic agents |
| 06/19/2001 | US6248341 Method of treating topical angiogenesis-related disorders |
| 06/19/2001 | US6248335 Ph control |
| 06/19/2001 | US6248327 Using antibody |
| 06/19/2001 | US6248326 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor |
| 06/19/2001 | US6248325 Glutathione s-transferase |
| 06/19/2001 | US6248320 Herpes simplex virus; genetic engineering |
| 06/19/2001 | US6248306 Cascade polymer complexes, process for their production and pharmaceutical agents containing said complexes |
| 06/19/2001 | US6248305 Boron heterocycle steroid mimics and associated pharmaceutical compositions and methods of use |
| 06/19/2001 | CA2190973C Novel 4,6-diarylpyrimidine derivatives and salts thereof |
| 06/19/2001 | CA2022539C Albumin derivatives with therapeutic functions |
| 06/14/2001 | WO2001042794A2 Method for identifying inhibitors of cytokinesis |
| 06/14/2001 | WO2001042488A2 Plasminogen activator assay involving an elastase inhibitor |
| 06/14/2001 | WO2001042484A1 Il-6 like polynucleotide |
| 06/14/2001 | WO2001042472A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 06/14/2001 | WO2001042471A2 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | WO2001042470A1 Nucleic acid and protein expressed thereby and their involvement in stress |
| 06/14/2001 | WO2001042467A2 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 06/14/2001 | WO2001042461A2 Apoptin-associating protein |
| 06/14/2001 | WO2001042460A1 Polynucleotides, polypeptides, remedies for cancer and vaccines |
| 06/14/2001 | WO2001042450A1 Antibody binding to human airway trypsin-like enzyme and utilization thereof |
| 06/14/2001 | WO2001042368A1 Substituted phthalocyanines and their precursors |
| 06/14/2001 | WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001042301A1 Interferon-alpha induced gene |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042285A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them |
| 06/14/2001 | WO2001042275A1 Unsaturated 14,15-cyclopropane-androstanes, a method for their production and pharmaceutical compositions containing these compounds |
| 06/14/2001 | WO2001042274A1 14,15-cyclopropanosteroids of the 19-norandrostane series, method for producing said compounds and pharmaceutical preparation containing said compounds |
| 06/14/2001 | WO2001042270A1 Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions |
| 06/14/2001 | WO2001042267A1 Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositions |
| 06/14/2001 | WO2001042246A2 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 06/14/2001 | WO2001042241A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/14/2001 | WO2001042237A1 3-methyl-chromane or thiochromane derivatives |
| 06/14/2001 | WO2001042236A1 Metal salts of 3-methyl-chromane or thiochromane derivatives |
| 06/14/2001 | WO2001042235A1 3-ethyl-, 3-propyl- or 3-butyl-chroman and -thiochroman derivatives |